Inflamed site-specific drug delivery system based on the interaction of human serum albumin nanoparticles with myeloperoxidase in a murine model of experimental colitis-Reference-Cited by-同舟云学术

Inflamed site-specific drug delivery system based on the interaction of human serum albumin nanoparticles with myeloperoxidase in a murine model of experimental colitis

Published:2018-04 Issue: Volume:125 Page:141-147
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

Iwao Yasunori,Tomiguchi Izumi,Domura Ayaka,Mantaira Yusuke,Minami Akira,Suzuki Takashi,Ikawa Takashi,Kimura Shin-ichiro,Itai Shigeru

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference29 articles.

1. Epidemiology and risk factors for IBD;Ananthakrishnan;Nat. Rev. Gastroenterol. Hepatol.,2015

2. Pro-inflammatory cytokines in the pathogenesis of IBD;Strober;Gastroenterology.,2011

3. Cytokines in inflammatory bowel disease;Neurath;Nat. Rev. Immunol.,2014

4. Ulcerative colitis: current treatment strategies and future prospects;Garud;Therap. Adv. Gastroenterol.,2009

5. Current and emerging drugs for the treatment of inflammatory bowel disease;Triantafillidis;Drug Des. Devel. Ther.,2011

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioinformatics analysis of oxidative stress genes in the pathogenesis of ulcerative colitis based on a competing endogenous RNA regulatory network;PeerJ;2024-08-16

2. Oral Formulation of 5-Aminosalicylic Acid-Hemoglobin Bio-Adhesive Nanoparticles Enhance Therapeutic Efficiency in Ulcerative Colitis Mice: A Preclinical Evaluation;Journal of Pharmaceutical Sciences;2024-08

3. Mucoadhesive Mesalamine Prodrug Nanoassemblies to Target Intestinal Macrophages for the Treatment of Inflammatory Bowel Disease;ACS Nano;2024-06-13

4. An Overview of Biopolymers for Drug Delivery Applications;Applied Sciences;2024-02-08

5. Marine phospholipid nanoliposomes: A promising therapeutic approach for inflammatory bowel disease: Preparation, safety, and efficacy evaluation;Colloids and Surfaces B: Biointerfaces;2024-02